FOLLOW US

All Osteoporosis Articles

Eating a Mediterranean Diet May Help Prevent Hip Fractures
A study published online by JAMA Internal Medicine reviewed the bone-protective benefits of several high-quality types of diets, including the DASH diet (used to lower blood pressure) and the Mediterranean diet. 
Experimental Osteoporosis Drug Builds Bone, Cuts Fracture Risk
The experimental osteoporosis drug abaloparatide, currently under review by the FDA, worked as well as the only bone-building medication currently on the US market at decreasing fracture risk in a new study. 
Being Obese Can Lead to Weak Bones
A new study published in the journal Metabolism found that obesity and type 2 diabetes led to weakened bones. 
Medications Reduced Risk of Repeat Fragility Fractures by 40 Percent
Medications that improve bone health can help men and women who have suffered one so-called fragility fracture avoid another one, new research has found.
Earlier Age at Menopause Linked to Chemicals in Common Household Products and the Environment
Women with high levels of certain chemicals in their body experience menopause 2 to 4 years earlier than women with lower levels of chemicals known as endocrine-disrupting chemicals. These chemicals are found in the environment as well as common household items and beauty products.
Boost Your Bone Health with Calcium and Vitamin D Supplements
Calcium and Vitamin D play an important role in building and maintain health strong bones
To boost bone health, your doctor may recommend both calcium and Vitamin D supplements. Calcium, along with phosphorous, is one of the main minerals the body needs to create bone cells. The body also depends on calcium for a number of bodily functions — supporting the nerves, heart and other muscles in addition to some organs.
Among women, osteoporotic hip fracture dramatically increases risk of death within one year
It is well established that hip fractures can increase mortality among osteoporosis patients, but a new study conducted in Oregon found that this injury puts elderly women at a much greater risk of death within the year following the fracture.
Break me twice, shame on you: Among osteoporotic men, first vertebral fracture boosts risk of second
Data presented at the annual conference of the American Society for Bone and Mineral Research (ASBMR) indicates that male osteoporosis patients who suffer one vertebral pressure fracture have a significantly increased risk of experiencing another.
Osteoporosis drug may extend survival in older, not younger, breast cancer patients
Though initially approved by the U.S. Food and Drug Administration (FDA) for use among osteoporosis patients, zoledronic acid may double as a life-extending therapy for older women with breast cancer.
Scientists pinpoint gene that carries osteoporosis risk
While heredity is known to play a major role in an individual's likelihood of developing osteoporosis, until recently scientists could only point to a handful of genes that appear to confer this risk. However, all that has begun to change.
Osteoporosis drug may double as pain reliever for metastasized prostate cancer
While bisphosphonates are currently prescribed as a treatment for osteoporosis, one variety of the medication may soon be repurposed as a pain reliever for prostate cancer patients with bone metastases.
Experts weigh the benefits of 'drug holiday' from osteoporosis medications
While bisphosphonates and other osteoporosis medications are not meant to be taken for decades on end, some physicians recommend that patients who respond well to several years of such pharmaceutical treatments consider taking a "drug holiday."
Heavy alcohol consumption can fast-track osteoporosis onset
While light alcohol consumption does not harm bone health, multiple studies have shown that heavy drinking can drastically interfere with bone turnover and accelerate the onset of osteoporosis.
Computer simulation models economic savings from adherence to osteoporosis medications
Most osteoporosis patients are aware of the individual physical impact of sticking to their treatment regimen, but it can be harder to conceptualize the economic savings that broad adherence to medications can have.
Low socioeconomic status is associated with higher bone turnover, osteoporosis risk
Many physiological factors affect the rate at which bones break down and reform their mineral content, but new research conducted at the University of California, Los Angeles (UCLA) suggested that socioeconomic status (SES) may also have some bearing on bone turnover and the risk of osteoporosis.
SHOW MAIN MENU
SHOW SUB MENU